PhRMA has reported that 394 drugs and vaccines are being developed by U.S. biopharmaceutical companies. The treatments, either under review by the FDA or in clinical trials, include 15 medicines for parasitic infections, 24 for fungal infections, 124 for bacterial infections and 226 for viral infections.

Full Story:

Related Summaries